文献速递肝病

慢加急性肝衰竭3级患者是否应获得更高的肝移植优先权?

Should patients with acute-on-chronic liver failure grade 3 receive higher priority for liver transplantation?
PubMed 文献 · J Hepatol · 2023-01-01

本文以辩论形式探讨慢加急性肝衰竭3级(ACLF-3)患者是否应获得更高的肝移植优先权,并引用一例62岁男性酒精相关肝硬化失代偿、合并多器官衰竭的临床病例。

要点

  • ACLF-3患者若不行肝移植死亡风险极高,但移植时机与优先权分配尚存争议。
  • 病例为62岁男性肝硬化失代偿患者,入院时MELD-Na评分31、CLIF-C ACLF评分67。
  • 第7天列入等待名单当日发生大量静脉曲张出血伴低血容量休克,第10天仍为ACLF-3。

核心结论

  • 本文围绕ACLF-3患者是否应获得更高肝移植优先权展开辩论,未给出单一结论性推荐。

研究设计与样本

  • 辩论类文章,引用一例62岁男性酒精相关肝硬化失代偿、合并代谢性疾病的临床病例。

主要发现

  • 患者入院时白细胞计数12.1 G/L,国际标准化比值2.1,肌酐2.4 mg/dl,钠133 mmol/L,总胆红素7 mg/dl,乳酸5.5 mmol/L,MELD-Na评分31,CLIF-C ACLF评分67。
  • 第7天列入肝移植等待名单,同日发生大量静脉曲张出血伴低血容量休克,需特利加压素、输注3单位红细胞及内镜下套扎治疗。
  • 第10天患者以小剂量去甲肾上腺素0.03 μg/kg/min维持稳定,无新发脓毒症或出血,但因2级肝性脑病仍插管并接受肾脏替代治疗,乳酸3.1 mmol/L。
  • 患者目前为ACLF-3,伴肝、肾、凝血、循环和呼吸五个器官衰竭,不进行肝移植死亡风险极高。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In this debate, the authors consider whether patients with acute-on-chronic liver failure grade 3 (ACLF-3) should receive higher liver transplant priority, with reference to the following clinical case: a 62-year-old male with a history of decompensated alcohol-associated cirrhosis, with recurrent ascites and hepatic encephalopathy, and metabolic comorbidities (type 2 diabetes mellitus, arterial hypertension and a BMI of 31 kg/m2). A few days following evaluation for liver transplantation (LT), the patient was admitted to the intensive care unit and placed on mechanical ventilation for neurological failure, FiO2 of 0.3 with a SpO2 of 98%, and started on norepinephrine at 0.62 μg/kg/min. He had been abstinent since the diagnosis of cirrhosis a year prior. Laboratory results at admission were: leukocyte count 12.1 G/L, international normalised ratio 2.1, creatinine 2.4 mg/dl, sodium 133 mmol/L, total bilirubin 7 mg/dl, lactate 5.5 mmol/L, with a MELD-Na score of 31 and a CLIF-C ACLF score of 67. On the 7th day after admission, the patient was placed on the LT waiting list. On the same day, he had massive variceal bleed with hypovolemic shock requiring terlipressin, transfusion of three red blood cell units, and endoscopic band ligation. On day 10, the patient was stabilised with a low dose of norepinephrine 0.03 μg/kg/min, with no new sepsis or bleeding. However, the patient was still intubated for grade 2 hepatic encephalopathy and on renal replacement therapy with a lactate level of 3.1 mmol/L. The patient is currently categorised as having ACLF-3, with five organ failures (liver, kidney, coagulation, circulation, and respiration). Based on the severity of his liver disease and multiorgan failure, the patient is at an exceedingly high risk of death without LT. Is it appropriate to perform LT in such a patient?

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Artru F, Goldberg D, Kamath PS, et al. Should patients with acute-on-chronic liver failure grade 3 receive higher priority for liver transplantation? J Hepatol. 2023. PMID: 37208098. doi:10.1016/j.jhep.2022.12.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。